The Pfizer logo is seen at their world headquarters in New York April 28, 2014. Reuters/Andrew Kelly Pfizer Inc said on Wednesday the first formal late-stage trial of its approved treatment for advanced breast cancer, Ibrance, was stopped early after the medicine met its goal of delaying progression of the disease in previously treated patients. […]

COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, ReSound introduced the first hearing aid app designed specifically for Apple Watch. Available immediately to Apple Watch wearers, the ReSound Smart™ app for Apple Watch offers a new, streamlined user experience, allowing users to take advantage of seamless, on-the-go control, right from their wrist. The ReSound Smart app for Apple Watch marks the latest of the company’s efforts to bring forward-looking solutions […]

Medical Marijuana Extract Curbs Seizure Frequency In Early Trial Of Epilepsy Patients Epilepsy Researchers Hope to Replicate Promising Cannabidiol Findings in Randomized Controlled Studies A new study led by epilepsy specialists at NYU Langone Medical Center shows that some children and adults with treatment-resistant epilepsy may benefit from a treatment regimen including cannabidiol, a compound […]

Reuters Health | Tue Apr 14, 2015 5:22pm EDT BY BEN GRUBER BERKELEY, CALIFORNIA – Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool  for drug development as well as pave the way toward personalizing treatments for patients with heart conditions. […]

4/15/2015 8:43:44 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy  Phase 3 Top-Line Results Show IBRANCE in Combination with Fulvestrant Meets Progression-Free Survival (PFS) Primary Endpoint NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that […]

A new study shows that after a divorce people have an increased lifetime risk for heart attacks (myocardial infarction). Although previous studies have found that MIs occur more frequently in people who are divorced, this is the first study to prospectively examine the lifetime relationship between divorce and MI. In a paper published in Circulation: Cardiovascular […]

As the waistline of Americans has increased, so has the incidence of Type 2 diabetes. Startling data from the Centers for Disease Control  shows that that prevalence of this disease, which is directly related to obesity, now exceeds 9% in the adult population. It was less than half that rate in 1996. Furthermore, there doesn’t […]

It was 60 years ago yesterday that the nation heaved an enormous collective sigh of relief. The largest clinical trial for a vaccine in history had concluded, the data had been collected and analyzed, and the results were announced on April 12, 1955, coincidentally the ten-year anniversary of polio sufferer Franklin D. Roosevelt’s death: Jonas […]

There’s a lot of talk these days about the use of genomics and proteomics to develop personalized clinical treatments and improve the quality of our lives.  At a high level, genomics is essentially the study of a person’s genome and the use of its genes.  Proteomics is the study of the full set of proteins […]

Results from using Biogen’s experimental nerve repair drug in a disease of the eye were “mildly encouraging,” experts say, keeping alive the hope that the medicine might work in multiple sclerosis. The results will be presented next week at the 67th Annual Meeting of the American Academy of Neurology (AAN) in Washington, DC. Forbes received […]